Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review
Author:
Publisher
Springer Science and Business Media LLC
Link
https://link.springer.com/content/pdf/10.1007/s42399-020-00521-8.pdf
Reference63 articles.
1. Bhattacharjee S, Banerjee M, Pal R. COVID-19-associated hemophagocytic lymphohistiocytosis and coagulopathy: targeting the duumvirate [published online ahead of print, 2020 Jun 24]. Indian Pediatr. 2020:S097475591600204.
2. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20. https://doi.org/10.1056/NEJMoa2002032.
3. Chen W, Li Z, Yang B, Wang P, Zhou Q, Zhang Z, et al. Delayed-phase thrombocytopenia in patients with coronavirus disease 2019 (COVID-19). Br J Haematol. 2020;190(2):179–84. https://doi.org/10.1111/bjh.16885.
4. Sahu KK, Siddiqui AD, Rezaei N, Cerny J. Challenges for management of immune thrombocytopenia during COVID-19 pandemic [published online ahead of print, 2020 Jul 3]. J Med Virol. 2020. https://doi.org/10.1002/jmv.26251.
5. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113(11):2386–93. https://doi.org/10.1182/blood-2008-07-162503.
Cited by 230 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Risk of Neurologic or Immune-Mediated Adverse Events After COVID-19 Diagnosis in the United States;2024-07-18
2. Post-COVID-19: Hematological Factors Changes in Patients at Three-- time Intervals;Current Medicinal Chemistry;2024-07-09
3. Characterization of Unique Pathological Features of COVID-Associated Coagulopathy: Studies with AC70 hACE2 Transgenic Mice Highly Permissive to SARS-CoV-2 Infection;PLOS Pathogens;2024-06-24
4. Assessing the impact of COVID-19 on acute leukemia patients: a comparative analysis of hematological and biochemical parameters;BMC Infectious Diseases;2024-06-11
5. COVID‐19‐induced immune thrombocytopenia management approach: A case report and literature review;Clinical Case Reports;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3